JPS63315001A - Method for sterilizing and deodorizing interior of shoes and insole used therein - Google Patents

Method for sterilizing and deodorizing interior of shoes and insole used therein

Info

Publication number
JPS63315001A
JPS63315001A JP14914687A JP14914687A JPS63315001A JP S63315001 A JPS63315001 A JP S63315001A JP 14914687 A JP14914687 A JP 14914687A JP 14914687 A JP14914687 A JP 14914687A JP S63315001 A JPS63315001 A JP S63315001A
Authority
JP
Japan
Prior art keywords
insole
drugs
shoes
benzoic acid
salicylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14914687A
Other languages
Japanese (ja)
Other versions
JPH0514565B2 (en
Inventor
修文 日高
俊幸 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teysan Pharmaceuticals Co Ltd
Original Assignee
Teysan Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teysan Pharmaceuticals Co Ltd filed Critical Teysan Pharmaceuticals Co Ltd
Priority to JP14914687A priority Critical patent/JPS63315001A/en
Publication of JPS63315001A publication Critical patent/JPS63315001A/en
Publication of JPH0514565B2 publication Critical patent/JPH0514565B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は足の臭いの防止、水虫の予防及び治療のための
、靴内の殺菌・防臭方法及びそれに使用するインソール
(靴の中敷)に関するものである。
[Detailed Description of the Invention] <Industrial Application Field> The present invention provides a method for sterilizing and deodorizing inside shoes and an insole (shoe insole) used therein for preventing foot odor and preventing and treating athlete's foot. It is related to.

〈従来の技術〉 生活習慣の変化に伴ない、靴を1日中履くことが多くな
ったこと等も関係して、足の臭いや水虫に悩む人が非常
に増加している。
<Conventional Technology> Due to changes in lifestyle and people increasingly wearing shoes all day long, the number of people suffering from foot odor and athlete's foot has increased significantly.

これら足の臭いや水虫の防止、治療法としては、民間療
法も含めて多種多様のものが、提案され試みられている
A wide variety of methods for preventing and treating foot odor and athlete's foot, including folk remedies, have been proposed and tried.

しかし、これらの方法をもってしても、患部に存在する
水虫の原因となる菌を全滅させるのは難しいと推測され
る。しかも、仮りに全滅させ得たとしても、従来から層
いていた靴を再び腹くと、その靴の中に付着している菌
が再び足に移行し繁殖していくし、また靴を変えても、
水虫の原因となる菌に触れる危険は、家庭や公衆の場で
無限にあると考えねばならない。
However, even with these methods, it is presumed that it is difficult to completely eradicate the bacteria that cause athlete's foot present in the affected area. What's more, even if we were able to completely eradicate them, if the shoes that had been layered with them were used again, the bacteria that were inside those shoes would transfer to the feet and multiply again, and we would have to change shoes again. too,
We must consider that there is an infinite risk of coming into contact with the bacteria that causes athlete's foot, both at home and in public places.

一般に、水虫の治療には、ナフチオメートやその他のよ
り強力な薬物を、軟膏やチンキ等に加工したものが使ね
・れているが、水虫菌が単に皮膚表面のみでなく、表皮
の中や爪の下等に生息することも関係して、十分に効果
的な治療法はないのが現状である。
In general, naphthiomate and other more powerful drugs processed into ointments and tinctures are not used to treat athlete's foot, but the athlete's foot fungus is not only present on the skin surface, but also inside the epidermis and on the nails. Due to the fact that it lives in the lower parts of the earth, there is currently no fully effective treatment.

〈発明が解決しようとする問題点〉 本発明の目的は、従来の技術の問題点に鑑み、安息香酸
及び/又はサリチル酸を用いる、足の臭いの防止、水虫
の予防及び治療のための、靴内の殺菌・防臭方法及びそ
れに使用するインソールを提供することにある。
<Problems to be Solved by the Invention> In view of the problems of the prior art, an object of the present invention is to provide shoes for preventing foot odor and preventing and treating athlete's foot using benzoic acid and/or salicylic acid. The purpose of the present invention is to provide a method for sterilizing and deodorizing interiors, and an insole for use therein.

く問題を解決するための手段〉 本発明者らは、足の臭い、水虫の予防及び治療に効果的
な方法について鋭意検討した結果、足の臭いの紡止、水
虫の予防及び治療のためには、これらの大半が発生する
靴の内部全体で、これら臭いや水虫の原因となる細菌や
カビの繁殖を防げる条件をつくることが、基本的に大切
であること、そのような条件をつくるためには、揮発性
を有し、抗菌性を有する安息香酸及び/又はサリチル酸
を用い、雰囲気を弱い酸性に保つことが最も効果的であ
ることを見出し、さらに工夫を重ねて本発明に到達した
ものである。
Means for Solving the Problems As a result of intensive study on effective methods for preventing and treating foot odor and athlete's foot, the present inventors have developed a method for preventing and treating foot odor and athlete's foot. It is fundamentally important to create conditions that prevent the growth of bacteria and mold that cause these odors and athlete's foot throughout the interior of shoes, where most of these occur, and to create such conditions. We discovered that it is most effective to use benzoic acid and/or salicylic acid, which are volatile and have antibacterial properties, and to maintain a weakly acidic atmosphere, and through further efforts, we have arrived at the present invention. It is.

即ち、本発明は、安息香酸及び/又はサリチル酸を含有
せしめたインソールから、約33℃で0.2〜10#j
/時間の割合でこれら薬物を揮発させることを特徴とす
る靴内の殺菌・防臭方法である。
That is, the present invention provides an insole containing benzoic acid and/or salicylic acid, which produces 0.2 to 10 #j at about 33°C.
This is a method for sterilizing and deodorizing the inside of shoes, which is characterized by volatilizing these drugs at a rate of / hour.

本発明においては、靴の内部を必要にして十分なこれら
薬物の雰囲気にすることが特に大切であり、そのために
はインソールより安息香酸及び/又はサリチル酸が約3
3℃で0.2〜1ONI/時間の速度で放出される必要
がある。これら薬物の放出量が0,2ay/時間未満の
時は足の臭い防止も、水虫の予防の効果もほとんどない
か非常に小さい。一方、これら薬物の放出量が大きい程
、殺菌作用は大きくなるが、放出量が大きくなるにした
がって、持効化のための薬物所要量が大きくなり、コス
ト高となる。更に足に湿疹、カブレが発生することも起
こる。このような問題の発生を防ぐためには、これら薬
物の放出量は10η/時間以下にしなければならない。
In the present invention, it is particularly important to create a sufficient atmosphere of these drugs inside the shoe, and for this purpose, approximately 30% of benzoic acid and/or salicylic acid is added to the insole.
It should be released at a rate of 0.2-1 ONI/hour at 3°C. When the amount of these drugs released is less than 0.2 ay/hour, there is little or very little effect on preventing foot odor and athlete's foot. On the other hand, the greater the released amount of these drugs, the greater the bactericidal effect, but as the released amount becomes larger, the amount of drug required for sustained effect increases, leading to higher costs. Furthermore, eczema and rashes may occur on the feet. In order to prevent such problems from occurring, the amount of these drugs released must be 10 η/hour or less.

かかる本発明の目的は、インソールの少なくとも一部に
これら薬物徐放化部を設けることによって達成される。
This object of the present invention is achieved by providing these drug sustained release parts in at least a portion of the insole.

インソールは、通常、樹脂含浸不織布や多孔質プラスチ
ックシートから形成される。あるいはまた、厚さが1〜
10麿のウレタンフオームやゴムスポンジ等と、111
11布帛(111編物や不織布)を貼り合わせたシート
状物から形成される。
Insoles are typically formed from resin-impregnated nonwoven fabrics or porous plastic sheets. Alternatively, the thickness is 1~
10 Maro's urethane foam, rubber sponge, etc., and 111
It is formed from a sheet-like material made by laminating 111 fabrics (111 knitted fabrics or non-woven fabrics) together.

安息香酸及び/又はサリチル酸徐放化部を設けたインソ
ールの具体例としては、一つ目の例として、インソール
を形成する樹脂含浸不織布、多孔質プラスチックシート
、スポンジ等やmIl布帛(111編物や不織布)中に
これら薬物を含浸させたり、練込んだりすることにより
インソールの全体又は一部にこれら薬物を保持させて、
これら薬物の放出量を制御するようにしたものがある。
Specific examples of insoles provided with benzoic acid and/or salicylic acid sustained release portions include resin-impregnated nonwoven fabrics, porous plastic sheets, sponges, etc. that form the insole, mill fabrics (111 knitted fabrics, nonwoven fabrics, etc.). ) By impregnating or kneading these drugs into the insole, the entire or part of the insole retains these drugs,
Some drugs are designed to control the amount of these drugs released.

この場合、これら薬物の放出量は、薬物溶液の濃度や、
薬物の値を変えることによって制御することができ、0
.2〜1j19/時間のように比較的低い儂に保つ場合
に適している。低放出量のため抗菌作用がやや低い。
In this case, the amount of these drugs released depends on the concentration of the drug solution,
Can be controlled by changing the value of the drug, 0
.. It is suitable for keeping the speed relatively low, such as 2 to 1j19/hour. Antibacterial activity is somewhat low due to the low release amount.

より確実で持続的な効果を得るための2つ目の例として
は外周方向に貫通した孔を有する微多孔性の中空糸から
なる不織布、I物又は編物等の布帛を用い、この中空糸
の中空部内にこれら薬物を含浸させたもの(薬物保持体
)を、インソールの表面又は内部に組み込んでこれら薬
物を保持させ、これら薬物の放出口を制御するようにし
たものがある。この場合、これら薬物は微細結晶となっ
てこの中空糸内に存在するため、この中空糸からのこれ
ら薬物の放出量は、これら薬物溶液の濃度を変えたり、
中空率を変えたり、あるいは中空糸からなる布帛の形態
、例えば不織布、織物又は編物等の形態を変えることに
よって0.2〜10mg/時間又はそれ以上の範囲で制
御することができる。
A second example to obtain a more reliable and lasting effect is to use a fabric such as a nonwoven fabric, an I-type fabric, or a knitted fabric made of microporous hollow fibers having holes penetrating in the outer circumferential direction. There are some insoles in which a hollow part impregnated with these drugs (drug holding body) is incorporated into the surface or inside of the insole to hold the drugs and control the release port of the drugs. In this case, since these drugs are present in the hollow fiber as microcrystals, the amount of these drugs released from the hollow fiber can be controlled by changing the concentration of the drug solution,
It can be controlled in the range of 0.2 to 10 mg/hour or more by changing the hollowness ratio or the form of the fabric made of hollow fibers, such as nonwoven fabric, woven fabric, or knitted fabric.

本発明においては、上記に述べた例の中でも、2つ目の
方法がこれら薬物の保持量を大巾に高め、またこれら薬
物を前記範囲内でほぼ一定の値で持続的に放出できるの
で好ましく、しかもインソール着用時の屈伸・撮動によ
ってもこれら薬物が脱落することが非常に少なく安定す
るので、好ましい。
In the present invention, among the above-mentioned examples, the second method is preferred because it greatly increases the retention amount of these drugs and can sustainably release these drugs at a substantially constant value within the above range. Moreover, it is preferable because these drugs are stable with very little chance of falling off even when bending/stretching or photographing when wearing the insole.

かかる中空糸の材質としてはインソールとしての強度、
安息香酸やサリチル酸に対する安定性等からポリエチレ
ンテレフタレートが特に望ましい。
The material of such hollow fibers is its strength as an insole,
Polyethylene terephthalate is particularly desirable because of its stability against benzoic acid and salicylic acid.

安息香酸、サリチル酸はそれぞれ単独で用いてもよいが
併用すると抗菌作用は相乗的となりより好ましい。
Although benzoic acid and salicylic acid may be used alone, it is more preferable to use them in combination because the antibacterial action will be synergistic.

かかる薬物を上述の中空糸に含浸させる方法としてはこ
れら薬物をアセトン、メタノール、エタノール等の溶媒
に溶解した液中にこの中空糸を浸漬してもよく、これら
薬物を溶解した液を中空糸へ滴下接触させる方法等によ
り達成できる。
As a method for impregnating the above-mentioned hollow fibers with such drugs, the hollow fibers may be immersed in a solution in which these drugs are dissolved in a solvent such as acetone, methanol, or ethanol, and the solution in which these drugs are dissolved is applied to the hollow fibers. This can be achieved by a method such as dropping contact.

本発明においては、安息香酸及び/又はサリチル酸を含
有せしめた薬物保持体はインソールの先端部、即ち足の
指の当りに大きさ53×5α位で設置する時、効果の面
からもコストの面からも望ましい。
In the present invention, when the drug carrier containing benzoic acid and/or salicylic acid is installed at the tip of the insole, that is, around the toes, with a size of 53 x 5 Also desirable.

以下に実施例をあげて、本発明をさらに詳細に説明する
。実施例及び参考例中の部は重量部を示している。
The present invention will be explained in more detail with reference to Examples below. Parts in Examples and Reference Examples indicate parts by weight.

参考例1 空、毫からなる布帛の作成 テレフタル酸ジメチル297部、エチレングリコール2
65部、3.5−ジ(カルボメトキシ)ベンゼンスルホ
ン酸ナトリウム53部(テレフタル酸ジメチルに対して
11.7モル%)、酢酸マンガン4水塩0.084部及
び酢酸ナトリウム3水塩1.22部を精密基材ガラスフ
ラスコに入れ、常法に従ってエステル交換反応を行ない
、理論量のメタノールが留出した後反応生成物を精留塔
付重縮合用フラスコに入れ、安定剤として正リン酸の5
6%水溶液0.090部及び重縮合触媒として三酸化ア
ンチモン0.135部を加え、温度275℃で、常圧下
20分、真空度30履1下で15分間反応させた。得ら
れた共重合ポリマーの極限粘度は0.405.軟化点は
200℃であった。反応終了後共重合ポリマーを常法に
従いチップ化した。
Reference Example 1 Creation of fabric consisting of sky and shell 297 parts of dimethyl terephthalate, 2 parts of ethylene glycol
65 parts, 53 parts of sodium 3.5-di(carbomethoxy)benzenesulfonate (11.7 mol% based on dimethyl terephthalate), 0.084 part of manganese acetate tetrahydrate, and 1.22 parts of sodium acetate trihydrate. The mixture was placed in a precision base glass flask, and transesterification was carried out according to a conventional method. After the theoretical amount of methanol had been distilled off, the reaction product was placed in a polycondensation flask equipped with a rectification column, and orthophosphoric acid was added as a stabilizer. 5
0.090 part of a 6% aqueous solution and 0.135 part of antimony trioxide as a polycondensation catalyst were added, and the mixture was reacted at a temperature of 275° C. for 20 minutes under normal pressure and under a degree of vacuum of 30 mm for 15 minutes. The intrinsic viscosity of the obtained copolymer was 0.405. The softening point was 200°C. After the reaction was completed, the copolymer was made into chips according to a conventional method.

この共重合ポリマーのチップ15部と極限粘度0.64
0のポリエチレンテレフタレートのチップ85部とをナ
ウタ・ミキサー(線用鉄工所製)中で5分IXO混合し
た優、窒素気流中にて110℃で2時間、更に150℃
で7時間乾燥した後、二輪のスクリュ一式押出機を用い
て290℃で溶融混練してチップ化した。このチップの
極限粘度は0.520.軟化点は262℃であった。
15 parts of chips of this copolymer and an intrinsic viscosity of 0.64
0.85 parts of polyethylene terephthalate chips were mixed with IXO for 5 minutes in a Nauta mixer (manufactured by Line Iron Works), heated to 110°C for 2 hours in a nitrogen stream, and further heated to 150°C.
After drying for 7 hours, the mixture was melt-kneaded at 290° C. using a two-wheel screw extruder to form chips. The intrinsic viscosity of this chip is 0.520. The softening point was 262°C.

このチップを常法により乾燥し、紡糸口金に巾0.05
MR,径0.65である円形スリットの2個所が閉じた
円弧状開口部をもつものを使用し、常法に従って紡糸し
、外径と内径の比が2=1の中空糸(中空率25%)を
作った。この原糸は300デニール/24フイラメント
であり、この原糸を用い常法に従って延伸倍率4.2倍
で延伸し、71デニール/24フイラメントのマルチフ
ィラメントを得た。
The chips were dried in a conventional manner and placed in a spinneret with a width of 0.05 mm.
MR, a circular slit with a diameter of 0.65 and a circular opening with two closed arcuate openings was used, and the fiber was spun according to a conventional method, and the ratio of the outer diameter to the inner diameter was 2 = 1 (hollow ratio 25 %)made. This raw yarn was 300 denier/24 filaments, and was drawn according to a conventional method at a draw ratio of 4.2 times to obtain a multifilament of 71 denier/24 filaments.

このマルチフィラメントをメリヤス編地になし、常法に
より精練、乾燥後、1%のカセイソーダ水溶液で、沸1
1温度にて2時間処理してアルカリ減役率15%、吸水
速度3秒、吸水率83%、目付2509/rdの布帛を
得た。
This multifilament was knitted into a knitted fabric, and after scouring and drying by a conventional method, it was boiled at 1% in a 1% caustic soda aqueous solution.
The fabric was treated at 1 temperature for 2 hours to obtain a fabric with an alkali reduction rate of 15%, a water absorption rate of 3 seconds, a water absorption rate of 83%, and a basis weight of 2509/rd.

尚、吸水速度及び吸水率は次の方法によって測定した。Note that the water absorption rate and water absorption rate were measured by the following method.

(ω  水  1験法(JIS−11018に ず前述
の布帛を、アニオン性洗剤ザブ(花王石鹸社製)の0.
3%水溶液で家庭用電気洗濯機により40℃で30分の
洗濯を10回くり返し、次いで乾燥して得られる試料を
水平に張り、試料の上13の高さから水滴を1滴(0,
04cc) @下し、水′が完全に試料に吸収され反射
光が観測されなくなるまでの時間を測定する。
(Water 1 test method (JIS-11018)) The above-mentioned fabric was washed with anionic detergent Zabu (manufactured by Kao Soap Co., Ltd.) at 0.0%.
The sample was washed 10 times with a 3% aqueous solution at 40°C for 30 minutes in a household electric washing machine, and then dried.
04cc) @ and measure the time until water' is completely absorbed by the sample and reflected light is no longer observed.

+b+  吸水率測定法 布帛を乾燥して得られる試料を水中に30分以上浸漬し
た後、家庭用電気洗濯機の脱水機で5分間脱水する。乾
燥試料の重量と脱水後の試料の重量から下記式により求
めた。
+b+ Water Absorption Measuring Method A sample obtained by drying a fabric is immersed in water for 30 minutes or more, and then dehydrated for 5 minutes in a dehydrator of a household electric washing machine. It was calculated from the weight of the dry sample and the weight of the sample after dehydration using the following formula.

吸水率=[(脱水後の試料重量−乾燥試料重量)/(乾
燥試料重量)]x100(%) 前記した方法で得られた中空糸は、該中空糸表面全体に
散在し繊維方向に配列し、且つその少なくとも1部は中
空部まで貫通している微細孔を有する中空糸であった・ 実施例1〜3及び比較例1 参考例1で得られた中空糸からなる布帛から切りとった
、5aA×5cIRの大きざの中空糸試料に、第1表に
示す組成の安息香vI(BA)とサリチル酸(SA)を
アセトンに溶かし、中空糸試料に滴下したのち、風乾し
てアセトンを除きBAのみ(実施例1)、SAのみ(実
施例2)及び°“BAとSA”(実施例3)を保持する
ものとBA、SAを含有しない(比較例1)もののイン
ソール取付用の試料を得た。
Water absorption rate = [(Sample weight after dehydration - Dry sample weight) / (Dry sample weight)] x 100 (%) The hollow fibers obtained by the above method are scattered over the entire surface of the hollow fibers and arranged in the fiber direction. , and at least part of it was a hollow fiber having micropores that penetrated to the hollow part. Examples 1 to 3 and Comparative Example 1 5aA cut from the fabric made of the hollow fiber obtained in Reference Example 1 Benzoic vI (BA) and salicylic acid (SA) having the composition shown in Table 1 were dissolved in acetone and dropped onto a hollow fiber sample of ×5 cIR size, and then air-dried to remove acetone and only BA ( Samples for insole attachment were obtained, including those retaining Example 1), SA only (Example 2), BA and SA (Example 3), and those containing neither BA nor SA (Comparative Example 1).

これらの試料の、温度33℃恒温槽での酢酸の揮散速度
は、第1表に示した通りであった。
The volatilization rate of acetic acid in these samples in a constant temperature bath at 33° C. was as shown in Table 1.

これらの試料について、AATCC (T echnical  manual  of  
the  A l1ericanAssociatio
n  of  Textile  CheliStS 
 andColorists)のハローテストに準じ、
ハローの有無及び阻止帯の大きさで抗菌性の評価を行っ
た。
Regarding these samples, AATCC (Technical manual of
the Allerican Association
n of Textile CheliStS
According to the halo test of andColorists),
Antibacterial properties were evaluated based on the presence or absence of a halo and the size of the inhibition zone.

その結果は、第1表に示した通りであった。The results were as shown in Table 1.

尚試験菌にはAニブドウ状球菌(3,aureus) 
The test bacteria include A.ni Staphylococcus (3, aureus).
.

及びB:白瘤菌(l” 、n+entaqrophyt
es)を用いた。
and B: white fungus (l”, n+enterophyt
es) was used.

製剤の臭いは試験製剤を靴の中へ入れ33℃に加温した
時の臭いを嗅いで判断した。
The odor of the preparation was determined by putting the test preparation into a shoe and smelling it when heated to 33°C.

実施例4〜5 ポリエステル繊維からなるフェルト(厚み2 rMn>
を大きさ5GX5CIAに裁断したものの上に、BAo
、15g及びSA 0.159をアセトン1gに溶解し
た溶液を滴下したのちアセトンを風乾により除いたイン
ソール用の試料を得た〈実施例4)。本試料について実
施例1と同様に揮散速度、及び抗菌性を調べた。本試料
の場合、使用開始時には揮散速度は0.6■/hrであ
ったが、薬物の半分が揮散した時点での揮散速度は0,
3Itg/hr(実施例5)と漸減傾向であった。
Examples 4-5 Felt made of polyester fiber (thickness 2 rMn>
BAo on top of the cut into size 5GX5CIA
, 15g of SA and 1g of SA dissolved in 1g of acetone were dropped, and the acetone was removed by air drying to obtain a sample for an insole (Example 4). The volatilization rate and antibacterial properties of this sample were investigated in the same manner as in Example 1. In the case of this sample, the volatilization rate was 0.6 /hr at the beginning of use, but when half of the drug was volatilized, the volatilization rate was 0.
It was 3Itg/hr (Example 5) and showed a gradual decreasing trend.

抗菌性試験の結果を第1表に示した。The results of the antibacterial test are shown in Table 1.

第1表 抗菌性評価 上表において◎:大きいハローあり、O:中位のハロー
1Δ:小さいハロー、×:へローなしを示す。
Table 1 Antibacterial evaluation In the above table, ◎: large halo present, O: medium halo 1Δ: small halo, ×: no halo.

上記の様な性能を有する本試料(安息香酸及び/又はサ
リチル酸徐放化部)を、通常のインソールの表面に貼り
つけて、あるいはインソールの内部に埋め込むことによ
って、本発明のインソールを得ることができる。
The insole of the present invention can be obtained by pasting this sample (benzoic acid and/or salicylic acid sustained release part) having the above performance on the surface of a normal insole or embedding it inside the insole. can.

Claims (1)

【特許請求の範囲】 1、安息香酸及び/又はサリチル酸を含有せしめたイン
ソールから、0.2〜10mg/時間の割合で安息香酸
及び/又はサリチル酸を揮発させることを特徴とする靴
内の殺菌・防臭方法。 2、インソールの少なくとも一部に安息香酸及び/又は
サリチル酸徐放化部を設けたインソール。 3、安息香酸及び/又はサリチル酸徐放化部が、外周方
向に貫通した孔を有する微多孔性中空糸からなる布帛と
、該中空部内に保持された安息香酸及び/又はサリチル
酸とからなる特許請求の範囲第2項記載のインソール。
[Claims] 1. Sterilization in shoes, characterized by volatilizing benzoic acid and/or salicylic acid from an insole containing benzoic acid and/or salicylic acid at a rate of 0.2 to 10 mg/hour. Odor prevention method. 2. An insole in which at least a portion of the insole is provided with a sustained release portion of benzoic acid and/or salicylic acid. 3. A patent claim in which the benzoic acid and/or salicylic acid sustained release portion comprises a fabric made of microporous hollow fibers having holes penetrating in the outer circumferential direction, and benzoic acid and/or salicylic acid held within the hollow portion. The insole according to item 2 of the range.
JP14914687A 1987-06-17 1987-06-17 Method for sterilizing and deodorizing interior of shoes and insole used therein Granted JPS63315001A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14914687A JPS63315001A (en) 1987-06-17 1987-06-17 Method for sterilizing and deodorizing interior of shoes and insole used therein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14914687A JPS63315001A (en) 1987-06-17 1987-06-17 Method for sterilizing and deodorizing interior of shoes and insole used therein

Publications (2)

Publication Number Publication Date
JPS63315001A true JPS63315001A (en) 1988-12-22
JPH0514565B2 JPH0514565B2 (en) 1993-02-25

Family

ID=15468777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14914687A Granted JPS63315001A (en) 1987-06-17 1987-06-17 Method for sterilizing and deodorizing interior of shoes and insole used therein

Country Status (1)

Country Link
JP (1) JPS63315001A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009522385A (en) * 2005-12-30 2009-06-11 ラウゲマン ラボラトリーズ ビー.ブイ. Cleaning composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5340351A (en) * 1976-09-22 1978-04-12 Tatsuo Fukuoka Foot wear for skin disease
JPS5692502U (en) * 1979-12-17 1981-07-23
JPS57203808U (en) * 1981-06-23 1982-12-25
JPS5910603U (en) * 1982-02-25 1984-01-23 日東電工株式会社 shoe insoles
JPS62114504A (en) * 1985-11-15 1987-05-26 株式会社 フアラオン Insole of footwear

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910603B2 (en) * 1976-11-18 1984-03-10 三菱電機株式会社 Retro Directive Array Antenna

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5340351A (en) * 1976-09-22 1978-04-12 Tatsuo Fukuoka Foot wear for skin disease
JPS5692502U (en) * 1979-12-17 1981-07-23
JPS57203808U (en) * 1981-06-23 1982-12-25
JPS5910603U (en) * 1982-02-25 1984-01-23 日東電工株式会社 shoe insoles
JPS62114504A (en) * 1985-11-15 1987-05-26 株式会社 フアラオン Insole of footwear

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009522385A (en) * 2005-12-30 2009-06-11 ラウゲマン ラボラトリーズ ビー.ブイ. Cleaning composition

Also Published As

Publication number Publication date
JPH0514565B2 (en) 1993-02-25

Similar Documents

Publication Publication Date Title
JP5612551B2 (en) Manufacture of wound care products and materials suitable for their use
US7858106B2 (en) Antimicrobial fiber and its production method, and antimicrobial fiber product comprising the antimicrobial fiber, its production method and regeneration method
KR100320636B1 (en) Wound Protector
JP2006110393A (en) Wound dressing
JPWO2010074311A1 (en) Deodorant fiber products
JP4826382B2 (en) Antibacterial cellulose fiber and textile product for skin contact
US6528162B1 (en) Acrylic synthetic fiber, use thereof, and process for producing acrylic synthetic fiber
JPS63315001A (en) Method for sterilizing and deodorizing interior of shoes and insole used therein
JP2017040007A (en) Deodorant fiber and deodorant fabric
KR20040085417A (en) Fabric softener composition
JPH09302553A (en) Pile fabric
JPH0444524B2 (en)
JP2002194642A (en) Paper yarn woven/knitted fabric
KR100368476B1 (en) Alkaline Gas Absorbent Textiles
JPH05212094A (en) Sanitary articles
FI96971B (en) Fiber structure containing urea peroxide and its preparation process
JPS61231221A (en) Hollow yarn and production thereof
JP2005008991A (en) Roentgenographic contrast fiber and medical gauze using the same
CN102619085B (en) Deodorization polyamide fiber and preparation method thereof
JP2002030552A (en) Raschel fabric having deororizing and antimicrobial properties and product thereof
JPH032547B2 (en)
JP2000064149A (en) Structure containing fiber for preventing sweat odor and body odor
JPS6257937A (en) Production of deodorant acrylic synthetic fiber
CN118257139A (en) Gel antibacterial fabric and preparation method thereof
JPH09308A (en) Insole material for shoes